在乳腺癌中,RGS10缺乏促进了远程转移,因为它诱导了上皮细胞-介质细胞过渡
相关实验视频
Updated: Jun 16, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
Yang Liu1, Yi Jiang1, Peng Qiu2
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
eLife
|August 15, 2024
概括
调节G蛋白信号10 (RGS10) 在乳腺癌中起到瘤抑制作用. 较低的RGS10水平与转移的增加和患者预后的降低相关,突出显示了其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 远程转移显著导致乳腺癌死亡率.
- 表皮介质转变 (EMT) 是驱动癌症转移的一个关键过程.
- 调节G蛋白信号 (RGS) 蛋白质参与调节各种癌症的转移.
研究的目的:
- 调查RGS10在上皮细胞-介质细胞转变 (EMT) 和乳腺癌转移中的作用.
- 为了确定RGS10蛋白水平在乳腺癌患者的预后意义.
主要方法:
- 对乳腺癌组织中的RGS10蛋白水平与正常组织的比较分析.
- 在具有不同侵略性的乳腺癌细胞系中评估RGS10表达 (MDA-MB-231,MCF7,SKBR3).
- 功能性研究涉及RGS10基因沉默在SKBR3细胞中,以评估对EMT,迁移和入侵的影响.
主要成果:
- 与正常组织相比,乳腺癌组织中的RGS10蛋白水平显著降低.
- 较低的RGS10表达与乳腺癌患者的更差预后相关.
- 缺少RGS10促进了EMT,迁移和乳腺癌细胞的入侵,由利波卡林-2和MIR539-5p介导.
结论:
- 在乳腺癌中,RGS10作为瘤抑制剂起作用.
- RGS10是乳腺癌的一个有价值的预后生物标志物.
- RGS10代表了缓解乳腺癌转移的潜在治疗标.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K

